Prosecution Insights
Last updated: April 19, 2026
Application No. 18/277,158

METHOD FOR PRODUCING CYCLOHEXENONE COMPOUND

Non-Final OA §103
Filed
Aug 14, 2023
Examiner
WITHERSPOON, SIKARL A
Art Unit
1692
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Api Corporation
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
1y 11m
To Grant
65%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allow Rate
1403 granted / 1630 resolved
+26.1% vs TC avg
Minimal -21% lift
Without
With
+-21.0%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 11m
Avg Prosecution
36 currently pending
Career history
1666
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
44.6%
+4.6% vs TC avg
§102
19.1%
-20.9% vs TC avg
§112
17.5%
-22.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1630 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Shen et al. (Organic Letters, 2007) and Begue et al. (Synthetic Communications, 1992) in combination. The claims are drawn to a method for producing a cyclohexenone compound by isomerization of a raw material including a compound represented by formula (4) and an isomerization catalyst, to form the compound represented by formula (3). PNG media_image1.png 294 210 media_image1.png Greyscale Further limitations include the isomerization catalyst being a ruthenium-containing catalyst; forming the compound of formula (3) by cyclization of a compound of formula (2) in the presence of a solvent and a strong acid; PNG media_image2.png 172 214 media_image2.png Greyscale and reacting a compound of formula (1) with methyl vinyl ketone in a solvent, and in the presence of a base, to obtain the compound of formula (2). PNG media_image3.png 104 222 media_image3.png Greyscale Begue et al. teach a process, wherein a compound represented by instant formula (1) is reacted with methyl vinyl ketone, in the presence of benzene as solvent, and sodium hydride base, to produce a compound represented by formula (2). The compound of formula (2) undergoes cyclization in the presence of acetic acid/piperidine in benzene as solvent, thereby producing a cyclohexene compound (page 574). The differences between Begue et al. and the present invention are that the former uses acetic acid/piperidine for the cyclization step, not a “strong acid”, such as sulfuric acid (as used in the present examples), and therefore produces a trifluoromethylated cyclohexenone compound that still has a -COOEt group attached to the ring; and, Begue et al. do not teach isomerization of the cyclohexenone ring, resulting in double bond migration. A person having ordinary skill in the art would know how to substitute the acetic acid/piperidine reagents used in the cyclization step taught by Begue et al. in order to remove the ethyl carboxylate group from the compound of formula (1) taught by Begue et al., if so desired. Shen et al. teach the isomerization (double bond migration) of a substituted cyclohexenone compound using a ruthenium-containing catalyst, in a dichloromethane solvent, at a temperature of 23°C (page 1058). In view of the combined reference teachings, it would have been obvious to a person having ordinary skill in the art, looking for a means of isomerizing (migrating the double bond) a substituted cyclohexenone compound, such as compound (1) taught by Begue et al., to employ the process taught by Shen et al., using a ruthenium-containing catalyst, since Shen et al. teach a successful double bond migration for substituted cyclohexenone compounds. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SIKARL A WITHERSPOON whose telephone number is (571)272-0649. The examiner can normally be reached M-F 9am-9pm IFP. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SIKARL A WITHERSPOON/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Aug 14, 2023
Application Filed
Feb 21, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599897
DIRECT CATALYTIC CONVERSION OF ALCOHOLS TO OLEFINS OF HIGHER CARBON NUMBER WITH REDUCED ETHYLENE PRODUCTION
2y 5m to grant Granted Apr 14, 2026
Patent 12600690
METHOD OF ETHANOL CONVERSION TO HIGHER CARBON COMPOUNDS
2y 5m to grant Granted Apr 14, 2026
Patent 12595219
CONTINUOS FLOW SYNTHESIS OF CANNABIDIOL
2y 5m to grant Granted Apr 07, 2026
Patent 12595222
CURCUMINOIDS, ANALOGS THEREOF, AND METHODS OF MAKING THE SAME
2y 5m to grant Granted Apr 07, 2026
Patent 12595221
HYDROFORMYLATION PROCESSES
2y 5m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
65%
With Interview (-21.0%)
1y 11m
Median Time to Grant
Low
PTA Risk
Based on 1630 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month